Assessment of a revolving drug fund for essential asthma medicines in Benin

被引：5

作者：

Agodokpessi G. ^{[1
]}

Aït-Khaled N. ^{[2
]}

Gninafon M. ^{[1
]}

Tawo L. ^{[1
]}

Bekou W. ^{[1
]}

Perrin C. ^{[2
]}

Bissell K. ^{[2
]}

Billo N. ^{[2
]}

Enarson D.A. ^{[2
]}

Chiang C.-Y. ^{[2
,3
,4
]}

机构：

[1] Centre National Hospitalier de Pneumo phtisiolologie, Cotonou

[2] International Union Against Tuberculosis and Lung Disease, 68,boulevard Saint-Michel, Paris

[3] Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei

[4] Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei

来源：

Journal of Pharmaceutical Policy and Practice | / 8卷 / 1期

关键词：

Asthma; Beclometasone; Inhaled corticosteroid; Revolving drug fund;

D O I：

10.1186/s40545-015-0033-7

中图分类号：

学科分类号：

摘要：

Objectives: Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to 2013. Methods: We reviewed the process in establishing the RDF. We assessed cost and sale price of asthma medicines, expenditure of the RDF in procuring asthma medicines and other tools, revenue generated by sales of medicines to patients, and balance of capital as of 31 January 2013. We investigated whether there was interruption of supply of essential asthma medicines from 2008–2013. Results: The total amount of grants initially injected into the RDF was 24,101€. As of 31 January 2013, the capital of the RDF, including the deposit in the RDF bank account (8,114€) and the value of inhalers in stock (12,172€), was equivalent to 20,586€, slightly less than the initial capital (24,101€). The decrease of capital was mainly because a number of inhalers were expired or provided free-of-charge (6,091€) and because part of the fund was used to procure other elements required for the management of asthma (4,338€). Thanks to a RDF, Benin maintained an uninterrupted supply of essential asthma medicines in asthma pilot sites from 2008–2013. Conclusion: The Benin experience demonstrated that in countries where universal health coverage was not yet in place, establishment of a RDF may help maintain an uninterrupted supply of essential medicines. © 2015 Morrow; licensee BioMed Central.

引用

页码：1 / 8

页数：7

共 20 条

[11]

Ali G.K.M., How to establish a successful revolving drug fund: The experience of Khartoum state in the Sudan, Bull World Health Organ, 87, pp. 139-142, (2009)

[12]

Ade G., Gninafon M., Tawo L., Ait-Khaled N., Enarson D.A., Chiang C.-Y., Management of asthma in Benin: The challenge of loss to follow-up, Public Health Action, 3, pp. 76-80, (2013)

[13]

Kan X.H., Chiang C.-Y., Enarson D.A., Rao H.L., Chen Q., Ait-Khaled N., Et al., Asthma as a hidden disease in rural China: Opportunities and challenges of standard case management, Public Health Action, 2, pp. 87-91, (2012)

[14]

Billo N.E., Asthma drug facility: From concept to reality, Int J Tuberc Lung Dis, 10, (2006)

[15]

Billo N.E., Good news: Asthma medicines for all, Int J Tuberc Lung Dis, 14, (2010)

[16]

Ait-Khaled N., Enarson D.A., Management of asthma in adults. A guide to essentials of good practice, (2005)

[17]

Ait-Khaled N., Enarson D.A., Chiang C.-Y., Marks G.B., Bissell K., Management of asthma: A guide to the essentials of good clinical practice, (2008)

[18]

Pan American Health Organization, About the PAHO Strategic Fund

[19]

The World Health Report, Health system financing: The path to universal coverage, (2010)

[20]

World Health Organization, Global action plan for the prevention and control of noncommunicable diseases 2013-2020, (2013)

← 1 2 →